Search research articles
Contact Us
Filters
Showing results (541-550 of 562) with videos related to
Page
of 57
Sort By:
Nature
|
July 9, 1998
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
B Staels, W Koenig, A Habib, et al.
Journal of Lipid Research
|
May 29, 2000
Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease
N Demeester, G Castro, C Desrumaux, et al.
Biochemical and Biophysical Research Communications
|
March 1, 2000
Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits
M Mackness, A Boullier, N Hennuyer, et al.
Circulation Research
|
September 6, 2005
Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages
E Rigamonti, L Helin, S Lestavel, et al.
The Journal of Biological Chemistry
|
May 29, 2000
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
M Guerre-Millo, P Gervois, E Raspé, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 17, 2004
REDD2 gene is upregulated by modified LDL or hypoxia and mediates human macrophage cell death
C Cuaz-Pérolin, C Furman, G Larigauderie, et al.
Brain : a Journal of Neurology
|
July 4, 2006
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study
F Picard, D Bruel, D Servent, et al.
Nature Medicine
|
January 3, 2001
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
G Chinetti, S Lestavel, V Bocher, et al.
Atherosclerosis
|
February 13, 2001
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding
F H de Man, F de Beer, A van der Laarse, et al.
Journal of the American College of Cardiology
|
October 8, 1997
Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty
M E Bertrand, E P McFadden, J C Fruchart, et al.
Page
of 57
Search research articles
Search
Showing results (541-550 of 562) with videos related to
Sort By:
Page
of 57
Nature
|
July 9, 1998
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
B Staels, W Koenig, A Habib, et al.
Journal of Lipid Research
|
May 29, 2000
Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease
N Demeester, G Castro, C Desrumaux, et al.
Biochemical and Biophysical Research Communications
|
March 1, 2000
Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits
M Mackness, A Boullier, N Hennuyer, et al.
Circulation Research
|
September 6, 2005
Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages
E Rigamonti, L Helin, S Lestavel, et al.
The Journal of Biological Chemistry
|
May 29, 2000
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
M Guerre-Millo, P Gervois, E Raspé, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 17, 2004
REDD2 gene is upregulated by modified LDL or hypoxia and mediates human macrophage cell death
C Cuaz-Pérolin, C Furman, G Larigauderie, et al.
Brain : a Journal of Neurology
|
July 4, 2006
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study
F Picard, D Bruel, D Servent, et al.
Nature Medicine
|
January 3, 2001
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
G Chinetti, S Lestavel, V Bocher, et al.
Atherosclerosis
|
February 13, 2001
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding
F H de Man, F de Beer, A van der Laarse, et al.
Journal of the American College of Cardiology
|
October 8, 1997
Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty
M E Bertrand, E P McFadden, J C Fruchart, et al.
Page
of 57